Document is current
Any future updates will be listed below
-
Authors
Cruz, Gabriela
Ramos-Cartagena, Jeslie M.
Torres-Russe, José L.
Colón-López, Vivian
Ortiz-Ortiz, Karen J.
Pericchi, Luis
Deshmukh, Ashish A.
Ortiz, Ana Patricia
-
Funding
Funding for this research was provided by:
Division of Cancer Prevention, National Cancer Institute (R25CA240120)
Division of Cancer Prevention, National Cancer Institute (2U54CA096297–18)
Division of Cancer Prevention, National Cancer Institute (R25CA240120)
Division of Cancer Prevention, National Cancer Institute (2U54CA096297–18)
Division of Cancer Prevention, National Cancer Institute (2U54CA096297–18)
Division of Cancer Prevention, National Cancer Institute (2U54CA096297–18)
Division of Cancer Prevention, National Cancer Institute (2U54CA096297–18)
Division of Cancer Prevention, National Cancer Institute (R25CA240120)
- License Information
-
More Information
Article History
Received: 19 May 2023
Accepted: 27 September 2023
First Online: 6 October 2023
Declarations
:
: This study was approved by the Institutional Review Board of the University of Puerto Rico Comprehensive Cancer Center and followed the Declaration of Helsinki (Protocol number: 2019–07-10).All participants provided telephone-based informed consent before they participated in the study.
: N/A.
: Dr. Ortiz reported receiving grants from the National Institutes of Health and Merck during the conduct of the study and reported consulting fees from Merck & Co outside the submitted work. Dr. Ortiz-Ortiz reported receiving grants from the Centers for Disease Control and Prevention National Program of Cancer Registries, the National Cancer Institute, Abbvie Corp, and Merck & Co outside the submitted work. Dr. Colón-López reported receiving consulting fees from Merck & Co outside the submitted work. All the other authors do not have competing interest.
